Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/15/2007US20070264277 Compositions and Methods of Use for Mgd-Csf in Disease Treatment
11/15/2007US20070264276 Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264256 polynucleotide sequence of a NTHi, polypeptides encoded by it and antibodies that bind to the polypeptide; detecting NTHi bacteria in a biological sample by contacting a polynucleotide to detect hybridization of the polynucleotide
11/15/2007US20070264251 C1q Related Protein
11/15/2007US20070264237 Use of Il-18 Binding Protein in Inflammations
11/15/2007US20070264236 Novel Therapeutic Fusion Proteins
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
11/15/2007US20070264234 Cytokine Variant Polypeptides
11/15/2007US20070264229 Peptides for Treatment of Autoimmune Disease
11/15/2007US20070264228 Methods for treating viral infection using il-28 and il-29
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007US20070264195 Modulation of Activity of Neurotrophins
11/15/2007CA2686559A1 Epigenetic regulatory complex for control of gene expression
11/15/2007CA2656824A1 Men1 is a marker and therapeutic target for breast and prostate cancer
11/15/2007CA2652599A1 Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
11/15/2007CA2652247A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007CA2651572A1 Use of cells containing a specific dna molecule as cytopathic agents to inhibit the proliferation of cells
11/15/2007CA2651348A1 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007CA2651199A1 Methods and compositions relating to zpa polypeptides
11/15/2007CA2651174A1 Chimeric t cell receptors and related materials and methods of use
11/15/2007CA2651125A1 Phage derived antimicrobial activities
11/15/2007CA2650580A1 A method for delivering a human chorionic gonadotropin (hcg) vaccine for long-acting antibody production
11/15/2007CA2650267A1 Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual
11/15/2007CA2649962A1 Hcv coreceptor and methods of use thereof
11/15/2007CA2649235A1 Insulin derivative
11/15/2007CA2648487A1 Polypeptide antagonist
11/15/2007CA2648484A1 Antibody-targeted cytokines for therapy
11/14/2007EP1855112A1 Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions
11/14/2007EP1854892A1 Modified viral surface proteins wich bind to cells of tumor vasculature
11/14/2007EP1854886A2 Cold-adapted equine influenza viruses
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854881A1 METHODS OF IDENTIFYING PURKINJE CELLS USING THE Corl2 GENE AS A TARGET
11/14/2007EP1854880A1 Methods and reagents for modulating cholesterol levels
11/14/2007EP1854879A1 Method of constructing novel higher plant and mehtod of promoting the growth of higher plant
11/14/2007EP1854809A1 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854488A1 Methods for treatment of hyperproliferative diseases using human MDA-7
11/14/2007EP1854475A1 Use of leptin for the prevention of excess body weight and composition containing leptin
11/14/2007EP1854471A1 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/14/2007EP1853717A2 Circular permutant gfp insertion folding reporters
11/14/2007EP1853711A2 New sources for, and types of, insecticidally active proteins, and polynucleotides that encode the proteins
11/14/2007EP1853707A2 Uses of il-23 antagonists in the treatment of diabetes mellitus
11/14/2007EP1853628A2 Sodium channel protein type iiii alpha-subunit splice variant
11/14/2007EP1853627A2 Gip analog and hybrid polypeptides with selectable properties
11/14/2007EP1853626A2 Amyloid-binding peptides, analogues and uses thereof
11/14/2007EP1853625A2 Compositions and methods for the diagnosis and treatment of tumor
11/14/2007EP1853624A2 Therapeutic peptides derived from urokinase plasminogen activator receptor
11/14/2007EP1853623A1 Animal product free system and process for purifying a botulinum toxin
11/14/2007EP1853622A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/14/2007EP1853621A1 Novel plasmid autonomously replicable in enterobacteriaceae family
11/14/2007EP1853323A2 Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by insulin-like growth factor binding protein-3 (igfbp-3)
11/14/2007EP1853312A2 Methods and compositions for modulating tweak and fn14 activity
11/14/2007EP1853307A1 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies
11/14/2007EP1853306A2 Polypeptides from staphylococcus aureus and methods of use
11/14/2007EP1853305A2 Survivin peptide vaccine
11/14/2007EP1853304A2 Modulation of muc1 activity
11/14/2007EP1716225B1 Method for the production of recombined proteins in eukaryontic host cells
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007EP1585384A4 Precise breeding
11/14/2007EP1567857B1 Method for screening modulators of mitochondrial functioning
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1499181A4 Vascularized human skin equivalent
11/14/2007EP1468022B1 Novel monoclonal antibody and nematode larval antigens
11/14/2007EP1425301B1 Therapeutic vaccine mixture for preventing and treating disorders in mammals
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1419390B1 High-throughput assays for the proteolytic activities of clostridial neurotoxins
11/14/2007EP1373503B1 Neurotrophic factors
11/14/2007EP1354034B1 Transgenic transchromosomal rodents for making human antibodies
11/14/2007EP1339433B1 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
11/14/2007EP1322666B1 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents
11/14/2007EP1317555B1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses
11/14/2007EP1309860B1 Method for screening peptides for use in immunotherapy
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1190259B1 Diagnostic assay for human matrix gla-protein and its use as a biomarker
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1117435B1 Mutant cholera holotoxin as an adjuvant
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007EP1092017B1 Novel gaba-b receptor
11/14/2007EP1007718B1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0960937B1 Novel semaphorin gene: semaphorin y
11/14/2007EP0866654B1 Method for treating hepatitis virus infection
11/14/2007EP0756628B1 Morphogenic protein-specific cell surface receptors and uses therefor
11/14/2007CN101072793A Il-7 variants with reduced immunogenicity
11/14/2007CN101072792A Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
11/14/2007CN101072585A Combination approaches for generating immune responses
11/14/2007CN101070548A Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
11/14/2007CN101070542A Intensified tubercle-resisting action of human interleukin 24
11/14/2007CN101070540A New dendritic cell co-stimulatory molecules
11/14/2007CN101070539A Sheep coenurus skrjabini specific gene and its separation and identification
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN101070343A Vascular endothelial cell growth factor variants and uses thereof
11/14/2007CN101070342A Balsm-pear-seed ribosome inactivated protein and its coding gene and use
11/14/2007CN101070341A Antibacterial peptide without mutagenic action
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
11/14/2007CN100348726C H9N2 type poultry influenze NS1 protein expression plasmid pET-NS1
1 ... 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 ... 2916